SANUWAVE Health, Inc. Common Stock Cash Flow Conversion Efficiency
SANUWAVE Health, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has a cash flow conversion efficiency ratio of 0.216x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($397.00K) by net assets ($1.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of SANUWAVE Health, Inc. Common Stock (2006–2025)
Cash flow conversion efficiency of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. This chart illustrates how SANUWAVE Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SNWV share price today for real-time trading data and today's change.
SANUWAVE Health, Inc. Common Stock Cash Flow Conversion Ratio Explained
SANUWAVE Health, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
SANUWAVE Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see SNWV stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dsr Wire
KO:069730
|
0.007x |
|
Broendbyernes IF Fodbold AS
CO:BIF
|
-0.007x |
|
Digital Mediatama Maxima PT
JK:DMMX
|
-0.035x |
|
Awilco LNG ASA
OL:ALNG
|
0.032x |
|
Pansari Developers Limited
NSE:PANSARI
|
0.253x |
|
International Development & Investment Corp
VN:IDI
|
0.011x |
|
Imago Mulia Persada Tbk PT
JK:LFLO
|
0.004x |
|
Big Sunshine Co Ltd
TW:1475
|
0.037x |
Annual Cash Flow Conversion Efficiency for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual cash flow conversion efficiency of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. Review SANUWAVE Health, Inc. Common Stock free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.62 Million | $3.88 Million | 2.394x | +1340.14% |
| 2024-12-31 | $-12.72 Million | $2.46 Million | -0.193x | -283.68% |
| 2023-12-31 | $-43.18 Million | $-4.54 Million | 0.105x | -74.90% |
| 2022-12-31 | $-41.01 Million | $-17.17 Million | 0.419x | +154.48% |
| 2021-12-31 | $-38.96 Million | $-6.41 Million | 0.165x | -82.25% |
| 2020-12-31 | $-13.72 Million | $-12.72 Million | 0.927x | +45.53% |
| 2019-12-31 | $-10.06 Million | $-6.41 Million | 0.637x | +170.14% |
| 2018-12-31 | $-15.36 Million | $-3.62 Million | 0.236x | +52.39% |
| 2017-12-31 | $-9.88 Million | $-1.53 Million | 0.155x | -66.57% |
| 2016-12-31 | $-6.91 Million | $-3.20 Million | 0.463x | -21.67% |
| 2015-12-31 | $-5.88 Million | $-3.47 Million | 0.591x | -86.27% |
| 2014-12-31 | $-1.55 Million | $-6.68 Million | 4.305x | +572.21% |
| 2013-12-31 | $-6.13 Million | $-3.92 Million | 0.640x | -2.69% |
| 2012-12-31 | $-6.52 Million | $-4.29 Million | 0.658x | -88.55% |
| 2011-12-31 | $-1.54 Million | $-8.83 Million | 5.748x | +930.25% |
| 2010-12-31 | $-10.52 Million | $-5.87 Million | 0.558x | -47.66% |
| 2009-12-31 | $-5.88 Million | $-6.27 Million | 1.066x | +85.53% |
| 2008-12-31 | $-72.97K | $-41.92K | 0.575x | +20.83% |
| 2007-12-31 | $-46.42K | $-22.07K | 0.475x | +25.28% |
| 2006-12-31 | $-10.73K | $-4.07K | 0.380x | -- |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more